Clinical Trial: Painful Diabetic Polyneuropathy Trial With a New Centrally Acting Analgesic
Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: A Randomized Phase IIa Trial Evaluating the Safety and Efficacy of a New Centrally Acting Analgesic in Subjects With Pain Due to Diabetic Polyneuropathy
Brief Summary: The purpose of this trial is to determine whether the new centrally active analgesic and MS Continus® are effective in the treatment of painful diabetic polyneuropathy.
Detailed Summary:
Sponsor: Grünenthal GmbH
Current Primary Outcome: Average daily pain intensity [ Time Frame: 5 days ]
Original Primary Outcome: Same as current
Current Secondary Outcome: Quality of life Neuropathic pain scale Amount and first time of Rescue medication Adverse events, ECG, Laboratory values [ Time Frame: 5 days ]
Original Secondary Outcome: Same as current
Information By: Grünenthal GmbH
Dates:
Date Received: April 3, 2009
Date Started: April 2009
Date Completion:
Last Updated: August 19, 2010
Last Verified: August 2010